Not only did a majority of each group say they hadn’t heard of biosimilars, but those who had heard of them had negative perceptions.
Education among providers around the safety and efficacy of biosimilars has been important for uptake of these agents, but education among patients and caregivers is also crucial. A study published in Journal of Pediatric Gastroenterology and Nutrition found that not only had a majority of pediatric patients and caregivers not heard of biosimilars, but those who had heard of them were more likely to have a negative perception.